Intellectus Partners’s Cytori Therapeutics Inc Series S Warrant CYTXZ Stock Holding History

Intellectus Partners’s Portfolio CYTXZ Stock Details CYTXZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-10,800	Closed	–	–	583
2018 Q3	$0	Hold	10,800	–	–	﹤0.01%	635
2018 Q2	$0	Buy	+10,800	New	+$467	﹤0.01%	631

Other funds holding CYTXZ

AFM

Anson Funds Management Dallas, Texas $1.68B AUM 373.57% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $177B AUM 39.86% 1-Year Est. Return

CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Intellectus Partners's CYTXZ Position: Q4 2018 in Review

Intellectus Partners sold out of Cytori Therapeutics Inc Series S Warrant (CYTXZ) in Q4 2018, closing a stake of 10,800 shares.

Intellectus Partners first reported a position in CYTXZ in Q2 2018 and held it in 2 quarters. The position peaked at $0 in Q3 2018. 7 funds tracked by Wall St. Rank hold CYTXZ as of Q4 2018.

Intellectus Partners reported no remaining Cytori Therapeutics Inc Series S Warrant position as of Q4 2018 after selling out during the quarter.
Intellectus Partners sold 10,800 Cytori Therapeutics Inc Series S Warrant shares in Q4 2018.
Intellectus Partners first reported a position in Cytori Therapeutics Inc Series S Warrant in Q2 2018 and held it in 2 quarters.
Intellectus Partners's Cytori Therapeutics Inc Series S Warrant position peaked at $0 in Q3 2018.
7 funds tracked by Wall St. Rank held Cytori Therapeutics Inc Series S Warrant as of Q4 2018.

Based on Intellectus Partners's 13F filing for Q4 2018, filed 14 Feb 2019.